88 related articles for article (PubMed ID: 25970831)
1. Nuclear Akt: target for breast cancer therapy?
Merz B; Malak PN; Rothfuss O
Cell Cycle; 2015; 14(13):2000. PubMed ID: 25970831
[No Abstract] [Full Text] [Related]
2. Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).
Jain MV; Jangamreddy JR; Grabarek J; Schweizer F; Klonisch T; Cieślar-Pobuda A; Łos MJ
Cell Cycle; 2015; 14(13):2109-20. PubMed ID: 26030190
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer banishes p27 from nucleus.
Blain SW; Massagué J
Nat Med; 2002 Oct; 8(10):1076-8. PubMed ID: 12357238
[No Abstract] [Full Text] [Related]
5. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL
Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301
[TBL] [Abstract][Full Text] [Related]
6. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
[TBL] [Abstract][Full Text] [Related]
7. Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt.
Tak J; Sabarwal A; Shyanti RK; Singh RP
Mol Cell Biochem; 2019 Aug; 458(1-2):49-59. PubMed ID: 30911957
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
Li F; Dong X; Lin P; Jiang J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
Wu FY; Wang SE; Sanders ME; Shin I; Rojo F; Baselga J; Arteaga CL
Cancer Res; 2006 Feb; 66(4):2162-72. PubMed ID: 16489017
[TBL] [Abstract][Full Text] [Related]
10. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
[TBL] [Abstract][Full Text] [Related]
11. Normal intestinal epithelial cell differentiation in the absence of p21 and p27: new insights from old knock-out mice.
Butler JE; Spear BT
Cancer Biol Ther; 2008 Jun; 7(6):880-1. PubMed ID: 18509258
[No Abstract] [Full Text] [Related]
12. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
13. Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.
Motti ML; De Marco C; Califano D; Fusco A; Viglietto G
Cell Cycle; 2004 Aug; 3(8):1074-80. PubMed ID: 15280662
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer.
Pérez-Tenorio G; Berglund F; Esguerra Merca A; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Int J Oncol; 2006 May; 28(5):1031-42. PubMed ID: 16596219
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice.
Yu L; Quinn DA; Garg HG; Hales CA
Circ Res; 2005 Oct; 97(9):937-45. PubMed ID: 16195480
[TBL] [Abstract][Full Text] [Related]
16. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.
Liang J; Zubovitz J; Petrocelli T; Kotchetkov R; Connor MK; Han K; Lee JH; Ciarallo S; Catzavelos C; Beniston R; Franssen E; Slingerland JM
Nat Med; 2002 Oct; 8(10):1153-60. PubMed ID: 12244302
[TBL] [Abstract][Full Text] [Related]
17. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
19. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
[TBL] [Abstract][Full Text] [Related]
20. ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.
Guo Q; Xiong Y; Song Y; Hua K; Gao S
Gene; 2019 Apr; 692():9-16. PubMed ID: 30641218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
